Immuno-Biological Laboratories Co (TSE:4570) Ending Cash Position : 円0.0 Mil (As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Immuno-Biological Laboratories Co Ending Cash Position?

Immuno-Biological Laboratories Co's Ending Cash Position for the quarter that ended in Sep. 2024 was 円0.0 Mil.

Immuno-Biological Laboratories Co's annual Ending Cash Position increased from Mar. 2022 (円449.2 Mil) to Mar. 2023 (円562.0 Mil) and increased from Mar. 2023 (円562.0 Mil) to Mar. 2024 (円675.0 Mil).

Immuno-Biological Laboratories Co Ending Cash Position Historical Data

The historical data trend for Immuno-Biological Laboratories Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuno-Biological Laboratories Co Ending Cash Position Chart

Immuno-Biological Laboratories Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Ending Cash Position

Get a 7-Day Free Trial

974.46

552.02

449.18

562.00

674.97

Immuno-Biological Laboratories Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Ending Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

Immuno-Biological Laboratories Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Immuno-Biological Laboratories Co's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	561.999	+	112.97
	=	675.0

Immuno-Biological Laboratories Co's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0.0

Immuno-Biological Laboratories Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Immuno-Biological Laboratories Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Immuno-Biological Laboratories Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuno-Biological Laboratories Co Ltd (TSE:4570) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

1091-1 Naka Aza-Higashida, Gunma, Fujioka, JPN, 375-0005

Website

http://www.ibl-japan.co.jp

Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.

Immuno-Biological Laboratories Co Headlines

No Headlines